Chalcogenopyrylium compounds as modulators of the ATP-binding cassette transporters P-glycoprotein (P-gp/ABCB1) and multidrug resistance protein 1 (MRP1/ABCC1).
Chalcogenopyrylium compounds as modulators of the ATP-binding cassette transporters P-glycoprotein (P-gp/ABCB1) and multidrug resistance protein 1 (MRP1/ABCC1).
复制标题
DOI:
10.1021/jm3004398
复制
发表时间:
2012-05
影响因子:
7.3
通讯作者:
Sean P. Ebert;Bryan R Wetzel;Robert L. Myette;G. Conseil;S. Cole;G. Sawada;T. Loo;M. Bartlett;D. Clarke;M. Detty
中科院分区:
文献类型:
--
作者:
Sean P. Ebert;Bryan R Wetzel;Robert L. Myette;G. Conseil;S. Cole;G. Sawada;T. Loo;M. Bartlett;D. Clarke;M. Detty
Twenty-seven chalcogenopyrylium derivatives varying in the heteroatom of the pyrylium core and substituents at the 2-, 4-, and 6-positions were examined for their effect on human MRP1-mediated uptake of tritiated estradiol glucuronide into inside-out membrane vesicles, their affinity for and ability to stimulate the ATPase activity of purified human P-glycoprotein (P-gp)-His(10), and their ability to promote uptake of calcein AM and vinblastine in multidrug-resistant cells. Differences in their effects on MRP1 and P-gp activity were noted, and a second set of thiopyrylium compounds with systematic substituent changes was examined to refine these differences further. Derivatives with tert-butyl substituents in the 2- and 6-positions had the lowest inhibitory activity toward both transporters. Derivatives with thioamide functionality in the 4-position were more active against MRP1 than derivatives with amide functionality. Conversely, derivatives with amide functionality in the 4-position were more active in P-gp than derivatives with thioamide functionality.